ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
65 hedge funds and large institutions have $163M invested in ChemoCentryx, Inc. in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 9 closing their positions.
46% more call options, than puts
Call options by funds: $328K | Put options by funds: $225K
10% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 70 → 65 (-5)
25% less capital invested
Capital invested by funds: $216M → $163M (-$53.3M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$742K |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$411K |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$300K |
| 4 |
Morgan Stanley
New York
|
-$208K |
| 5 |
Bank of New York Mellon
New York
|
-$208K |
CCXI Hedge Fund Activity: Q3 2015 in Review
65 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2015, worth a combined $163M — down 25% from $216M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CCXI and 4 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 22 added.
The largest buyer was BVF Inc, adding an estimated $2.19M. The largest seller was Renaissance Technologies, cutting an estimated $742K.
- 65 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2015, down from 70 in Q2 2015.
- Funds reported $163M of ChemoCentryx, Inc. stock for Q3 2015, down 25% quarter-over-quarter.
- 4 funds opened new ChemoCentryx, Inc. positions in Q3 2015 and 9 closed out, a net change of -5 holders.
- The largest ChemoCentryx, Inc. buyer in Q3 2015 was BVF Inc, an estimated $2.19M added.
- The largest ChemoCentryx, Inc. seller in Q3 2015 was Renaissance Technologies, an estimated $742K sold.
Based on aggregated 13F filings for Q3 2015.